IMFINZI 500MG/10ML INJECTION

IMFINZI 500MG/10ML INJECTION is administered intravenously into a vein in your arm or hand by a healthcare professional.

It works by blocking a protein called programmed death-ligand 1 (PD-L1), which is found on the surface of certain cancer cells. When PD-L1 binds to its receptor on T cells, it can inhibit the immune system's ability to recognize and attack cancer cells. By blocking the interaction between PD-L1 and its receptor, This drug allows T cells to recognize and attack cancer cells more effectively. It helps the immune system to fight the cancer and potentially slow or stop its growth.

Yes, IMFINZI 500MG/10ML INJECTION is often used in combination with other immunotherapy drugs, such as tremelimumab, to boost the immune response against cancer cells.

IMFINZI 500MG/10ML INJECTION is not recommended during pregnancy and it is unsafe because it may harm a developing fetus. Women who are pregnant or planning to become pregnant should discuss their treatment options with their doctor immediately.

IMFINZI 500MG/10ML INJECTION is not recommended in patients with autoimmune diseases, such as lupus, rheumatoid arthritis, or multiple sclerosis, who may be at an increased risk of side effects from this drug, and it should be used with caution in these patients.

It's important to discuss all medications, supplements, and herbal products you are taking with your doctor before starting IMFINZI 500MG/10ML INJECTION, as it can interact with other drugs.

IMFINZI 500MG/10ML INJECTION has the tendency to cause harm to unborn fetus. Inform your healthcare provider before starting this treatment if you are pregnant, or have a partner who can become pregnant. Your healthcare provider will conduct a pregnancy test before you start treatment with this drug. Discuss effective birth control methods with your healthcare provider and use them during treatment and for 8 weeks after your last dose. It is not known if this drug passes into breast milk. Hence, it is not recommended to breastfeed during this treatment. This drug can increase your risk of sunburn and skin damage, so it is important to wear protective clothing and sunscreen while moving outdoors. If you experience any gastrointestinal symptoms, such as diarrhea, abdominal pain, or nausea, be sure to inform your doctor immediately so that he may prescribe you antiemetic medicines also to prevent the symptoms.

IMFINZI 500MG/10ML INJECTION contains DURVALUMAB as its main molecule.

IMFINZI 500MG/10ML INJECTION is prescribed for Anti Cancer conditions.